Key facts
- IntusCare’s last known valuation is $6.0M (Apr 2021).
- It has raised $31.5M; the latest was Later Stage VC ($560K) in Mar 2026.
- Notable investors include Alumni Ventures, MassChallenge, Service Provider Capital, Deerfield Management, Westbound Equity Partners — 25 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 25 names
- ·Watchlist + deal alerts for IntusCare
- ·The full record, as it builds
Funding rounds
No funding rounds for IntusCare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About IntusCare
Developer of a healthcare analytics platform designed to improve care and reduce hospitalizations for socially vulnerable and clinically complex patients. The company has created a data-driven predictive analytics platform designed for organizations such as PACE programs, nursing homes, long-term care facilities and home care agencies and helps in identifying, correlating and visualizing healthcare trends, enabling patients to get healthcare at an affordable cost.
- Sector
- Healthcare
- HQ
- Providence, RI, United States
- Founded
- 2019
- Employees
- 102
- Website
- intuscare.com/
- Ownership
- Privately Held (backing)
IntusCare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in IntusCare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on IntusCare in its N-PORT filings yet. We sweep new filings monthly.